BACKGROUND: We sought to determine regional myofiber stress after Coapsys device (Myocor, Inc, Maple Grove, MN) implantation using a finite element model of the left ventricle (LV). Chronic ischemic mitral regurgitation is caused by LV remodeling after posterolateral myocardial infarction. The Coapsys device consists of a single trans-LV chord placed below the mitral valve such that when tensioned it alters LV shape and decreases chronic ischemic mitral regurgitation. METHODS: Finite element models of the LV were based on magnetic resonance images obtained before (preoperatively) and after (postoperatively) coronary artery bypass grafting with Coapsys implantation in a single patient. To determine the effect of Coapsys and LV before stress, virtual Coapsys was performed on the preoperative model. Diastolic and systolic material variables in the preoperative, postoperative, and virtual Coapsys models were adjusted so that model LV volume agreed with magnetic resonance imaging data. Chronic ischemic mitral regurgitation was abolished in the postoperative models. In each case, myofiber stress and pump function were calculated. RESULTS: Both postoperative and virtual Coapsys models shifted end-systolic and end-diastolic pressure-volume relationships to the left. As a consequence and because chronic ischemic mitral regurgitation was reduced after Coapsys, pump function was unchanged. Coapsys decreased myofiber stress at end-diastole and end-systole in both the remote and infarct regions of the myocardium. However, knowledge of Coapsys and LV prestress was necessary for accurate calculation of LV myofiber stress, especially in the remote zone. CONCLUSIONS: Coapsys decreases myofiber stress at end-diastole and end-systole. The improvement in myofiber stress may contribute to the long-term effect of Coapsys on LV remodeling.
RCT Entities:
BACKGROUND: We sought to determine regional myofiber stress after Coapsys device (Myocor, Inc, Maple Grove, MN) implantation using a finite element model of the left ventricle (LV). Chronic ischemic mitral regurgitation is caused by LV remodeling after posterolateral myocardial infarction. The Coapsys device consists of a single trans-LV chord placed below the mitral valve such that when tensioned it alters LV shape and decreases chronic ischemic mitral regurgitation. METHODS: Finite element models of the LV were based on magnetic resonance images obtained before (preoperatively) and after (postoperatively) coronary artery bypass grafting with Coapsys implantation in a single patient. To determine the effect of Coapsys and LV before stress, virtual Coapsys was performed on the preoperative model. Diastolic and systolic material variables in the preoperative, postoperative, and virtual Coapsys models were adjusted so that model LV volume agreed with magnetic resonance imaging data. Chronic ischemic mitral regurgitation was abolished in the postoperative models. In each case, myofiber stress and pump function were calculated. RESULTS: Both postoperative and virtual Coapsys models shifted end-systolic and end-diastolic pressure-volume relationships to the left. As a consequence and because chronic ischemic mitral regurgitation was reduced after Coapsys, pump function was unchanged. Coapsys decreased myofiber stress at end-diastole and end-systole in both the remote and infarct regions of the myocardium. However, knowledge of Coapsys and LV prestress was necessary for accurate calculation of LV myofiber stress, especially in the remote zone. CONCLUSIONS:Coapsys decreases myofiber stress at end-diastole and end-systole. The improvement in myofiber stress may contribute to the long-term effect of Coapsys on LV remodeling.
Authors: Jonathan F Wenk; Kay Sun; Zhihong Zhang; Mehrdad Soleimani; Liang Ge; David Saloner; Arthur W Wallace; Mark B Ratcliffe; Julius M Guccione Journal: J Biomech Eng Date: 2011-04 Impact factor: 2.097
Authors: P M McCarthy; M Takagaki; Y Ochiai; J B Young; T Tabata; T Shiota; J X Qin; J D Thomas; T J Mortier; R F Schroeder; C J Schweich; K Fukamachi Journal: J Thorac Cardiovasc Surg Date: 2001-09 Impact factor: 5.209
Authors: Judy Hung; Lampros Papakostas; Stephen A Tahta; Bruce G Hardy; Bruce A Bollen; Carlos M Duran; Robert A Levine Journal: Circulation Date: 2004-09-14 Impact factor: 29.690
Authors: Joe Luis Pantoja; Liang Ge; Zhihong Zhang; William G Morrel; Julius M Guccione; Eugene A Grossi; Mark B Ratcliffe Journal: Ann Thorac Surg Date: 2014-08-15 Impact factor: 4.330
Authors: Rafael Shimkunas; Zhihong Zhang; Jonathan F Wenk; Mehrdad Soleimani; Michael Khazalpour; Gabriel Acevedo-Bolton; Guanying Wang; David Saloner; Rakesh Mishra; Arthur W Wallace; Liang Ge; Anthony J Baker; Julius M Guccione; Mark B Ratcliffe Journal: Ann Thorac Surg Date: 2013-03-21 Impact factor: 4.330
Authors: Martin Genet; Lik Chuan Lee; Rebecca Nguyen; Henrik Haraldsson; Gabriel Acevedo-Bolton; Zhihong Zhang; Liang Ge; Karen Ordovas; Sebastian Kozerke; Julius M Guccione Journal: J Appl Physiol (1985) Date: 2014-05-29
Authors: Ashley E Morgan; Joe Luis Pantoja; Jonathan Weinsaft; Eugene Grossi; Julius M Guccione; Liang Ge; Mark Ratcliffe Journal: J Biomech Eng Date: 2016-02 Impact factor: 2.097
Authors: Joe Luis Pantoja; Zhihong Zhang; Mehrzad Tartibi; Kay Sun; Warrick Macmillan; Julius M Guccione; Liang Ge; Mark B Ratcliffe Journal: Ann Thorac Surg Date: 2015-09-02 Impact factor: 4.330
Authors: Hao Liu; João S Soares; John Walmsley; David S Li; Samarth Raut; Reza Avazmohammadi; Paul Iaizzo; Mark Palmer; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: Sci Rep Date: 2021-06-29 Impact factor: 4.379